<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36190999</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies.</ArticleTitle><Pagination><StartPage>e0274162</StartPage><MedlinePgn>e0274162</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0274162</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0274162</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is a principal causative agent of viral myocarditis, meningitis and pancreatitis. There is no vaccine available for clinical use. It has been demonstrated that the primary molecular determinant of virulence phenotype is located in the 5' UTR of the viral genome. Translation initiation of CVB3 RNA is directed by the IRES element situated in the 5'UTR. In the present study, we analyse the effects of single point mutations introduced in different positions in the domain V of the IRES RNA of CVB3 wild type. We characterize in vitro virus replicative capacitiy and translation efficiency and we test in vivo virulence of different CVB3 mutants produced by the introduction of different mutations in the domain V of IRES by site-directed mutagenesis to abolish its structure. Our results demonstrate that all RNA mutants display different levels of decreased replication and translation initiation efficiency in vitro. The translation defect was correlated with significant reduced viral titer of mutant particles in comparison with the wild type. When inoculated in mice, mutant viruses were checked for inflammation and necrosis.In vitro and in vivo Findings strongly suggest that the most attenuated mutant strain could be considered a candidate for live-attenuated CVB3 vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gharbi</LastName><ForeName>Jawhar</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9170-3403</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almalki</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben M'hadheb</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Virology and Antiviral Strategies Research Unit [UR17/ES30 ViroBiotech], Institute of Biotechnology, University of Monastir, Monastir, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020121">5' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020121" MajorTopicYN="N">5' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36190999</ArticleId><ArticleId IdType="pmc">PMC9529112</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0274162</ArticleId><ArticleId IdType="pii">PONE-D-21-32955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, In Fields&#x2019; Virology; Knipe DM, Howley PM Eds.;Williams &amp; Wilkins: Philadelphia, PA, USA, 2001; pp. 723&#x2013;775.</Citation></Reference><Reference><Citation>Lulla V, Dinan AM, Hosmillo M, Chaudhry Y, Sherry L, Irigoyen L et al.. An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells. Nature Microbiol. 2019;4, 280&#x2013;292. doi: 10.1038/s41564-018-0297-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0297-1</ArticleId><ArticleId IdType="pmc">PMC6443042</ArticleId><ArticleId IdType="pubmed">30478287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Chapman NM, Tu Z. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol.1992;122, 399&#x2013;409. doi: 10.1007/BF01317202</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317202</ArticleId><ArticleId IdType="pubmed">1310000</ArticleId></ArticleIdList></Reference><Reference><Citation>Souii A, Ben M&#x2019;hadheb-Gharbi M, Gharbi J. Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy. Mol. Biotechnol. 2013;55, 179&#x2013;202. doi: 10.1007/s12033-013-9674-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12033-013-9674-4</ArticleId><ArticleId IdType="pubmed">23881360</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda N, Kuhn RJ, Yang CF, Takegami T, Wimmer E. Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J. Virol.1986;60,43&#x2013;53. doi: 10.1128/JVI.60.1.43-53.1986</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.60.1.43-53.1986</ArticleId><ArticleId IdType="pmc">PMC253900</ArticleId><ArticleId IdType="pubmed">3018300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K, Egger D, Pfister T, Troxler M. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J. Virol.1990;64, 1156&#x2013;1163. doi: 10.1128/JVI.64.3.1156-1163.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.64.3.1156-1163.1990</ArticleId><ArticleId IdType="pmc">PMC249229</ArticleId><ArticleId IdType="pubmed">2154600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienz K, Egger D, Pfister T, Troxler M. Structural and functional characterization of poliovirus RNA replication complex. J. Virol.1992;66, 2740&#x2013;2747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241029</ArticleId><ArticleId IdType="pubmed">1313898</ArticleId></ArticleIdList></Reference><Reference><Citation>LIoyd RE. Enterovirus Control of Translation and RNA Granule Stress Responses. Viruses 2016;8, 93. doi: 10.3390/v8040093</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8040093</ArticleId><ArticleId IdType="pmc">PMC4848588</ArticleId><ArticleId IdType="pubmed">27043612</ArticleId></ArticleIdList></Reference><Reference><Citation>Coller BA, Chapman NM, Beck MA, Pallansch MA, Gauntt CJ, Tracy SM. Echovirus 22 is an atypical enterovirus. J. Virol.1990;64, 2692&#x2013;2701. doi: 10.1128/JVI.64.6.2692-2701.1990</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.64.6.2692-2701.1990</ArticleId><ArticleId IdType="pmc">PMC249448</ArticleId><ArticleId IdType="pubmed">2159539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature1988;334, 320&#x2013;325. doi: 10.1038/334320a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/334320a0</ArticleId><ArticleId IdType="pubmed">2839775</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier J, Kaplan G, Racaniello VR, Sonenberg N. Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5&#x2019; noncoding region. Mol. Cell Biol.1988;8,1103&#x2013;1112. doi: 10.1128/mcb.8.3.1103-1112.1988</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.8.3.1103-1112.1988</ArticleId><ArticleId IdType="pmc">PMC363253</ArticleId><ArticleId IdType="pubmed">2835660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev. Med. Virol.2001;11, 355&#x2013;368. doi: 10.1002/rmv.326</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.326</ArticleId><ArticleId IdType="pubmed">11746998</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kyung-Soo K, Drescher KM, Kuniyurki O, Tracy S. 5&#x2032; terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology 2008;375, 480&#x2013;491. doi: 10.1016/j.virol.2008.02.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.02.030</ArticleId><ArticleId IdType="pmc">PMC2440640</ArticleId><ArticleId IdType="pubmed">18378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A N &#x2019;guyen Y, Wehbe M et al.. Major Persistent 5&#x2032; Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues. Emer. Infect. Dis. 2016;22(8),1488&#x2013;1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4982168</ArticleId><ArticleId IdType="pubmed">27434549</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M N &#x2019;guyen Y, Mirand A et al.. Major 5&#x2032;terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes. Scientific Reports 2020;10,11947. doi: 10.1038/s41598-020-67648-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67648-5</ArticleId><ArticleId IdType="pmc">PMC7371739</ArticleId><ArticleId IdType="pubmed">32686697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane H, Caloone D, Lobert PE, Sane F, Dardenne O, Naquet P et al.. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J. Virol.2012;86, 11151&#x2013;11162. doi: 10.1128/JVI.00726-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00726-12</ArticleId><ArticleId IdType="pmc">PMC3457166</ArticleId><ArticleId IdType="pubmed">22855493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt CJ. Introduction and historical perspective on experimental myocarditis, InMyocarditis: from Bench to Bedside, Cooper, L.T., Totowa, Jr., Humana Press, NJ, 2003; pp. 1&#x2013;22.</Citation></Reference><Reference><Citation>Hober D, Sane F, Jaidane H, Riedweg K, Goffart A, Desailloud R. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.Clin. Exp. Immunol.2012;168, 47&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3390492</ArticleId><ArticleId IdType="pubmed">22385236</ArticleId></ArticleIdList></Reference><Reference><Citation>Hy&#xf6;ty H, Taylor KW. The role of viruses in human diabetes. Diabetologia2002;45, 1353&#x2013;1361. doi: 10.1007/s00125-002-0852-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-002-0852-3</ArticleId><ArticleId IdType="pubmed">12378375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer E, Hellen CU, Cao X. Genetics of poliovirus. Annu. Rev. Genet.1993;27, 353&#x2013;436. doi: 10.1146/annurev.ge.27.120193.002033</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ge.27.120193.002033</ArticleId><ArticleId IdType="pubmed">8122908</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin AB. Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA1965;194, 872&#x2013;876. doi: 10.1001/jama.194.8.872</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.194.8.872</ArticleId><ArticleId IdType="pubmed">5321495</ArticleId></ArticleIdList></Reference><Reference><Citation>Agol VI, Drozdov SG, Kolesnikova MS, Korolev MB, Tolskaya EA. Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol.1989;63, 4034&#x2013;4038. doi: 10.1128/JVI.63.9.4034-4038.1989</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.63.9.4034-4038.1989</ArticleId><ArticleId IdType="pmc">PMC251001</ArticleId><ArticleId IdType="pubmed">2548013</ArticleId></ArticleIdList></Reference><Reference><Citation>La Monica N, Racaniello VR. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol.1989;63, 2357&#x2013;2560. doi: 10.1128/JVI.63.5.2357-2360.1989</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.63.5.2357-2360.1989</ArticleId><ArticleId IdType="pmc">PMC250657</ArticleId><ArticleId IdType="pubmed">2539524</ArticleId></ArticleIdList></Reference><Reference><Citation>Woeses C, Winker R, Gutell RR. Architecture of ribosomal RNA-constraints on the sequence of tetra-loops. Proc. Nat. Acad. Sci. USA1990;87, 8467&#x2013;8471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54977</ArticleId><ArticleId IdType="pubmed">2236056</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlenbeck OC. Nucleic-acid structure-tetraloops and RNA folding. Nature1990;346, 613&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">1696683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pley H, Flaherty KM, McKay DB. Model for an RNA tertiary interaction from the structural of an intermolecular complex between a GAAA tetraloop and an RNA helix. Nature1994;372, 111&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">7526219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluck A, Endo Y, Wool IG. Ribosomal-RNA identity elements for ricin A-chain recognition and catalysis-analysis with tetraloop mutants. J. Mol. Biol.1992;226, 411&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">1379305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: Towards a better understanding of the relationship. Rev. Med. Virol.2010;20, 265&#x2013;280. doi: 10.1002/rmv.647</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.647</ArticleId><ArticleId IdType="pubmed">20629044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ja&#xef;dane H, Gharbi J, Lobert PE, Lucas B, Hiar R, M&#x2019;hadheb, MB, et al.. Prolomged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally inoculated Swiss mice. Microbiol. Immunol. 2006;50, 971&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179665</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#x2019;hadheb-Gharbi MB, El Hiar R, Paulous S, Jaidane H, Aouni M, Kean KM, et al.. Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation. J. Mol. Microbiol. Biotechnol. 2008;14, 147&#x2013;156. doi: 10.1159/000107369</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000107369</ArticleId><ArticleId IdType="pubmed">17693702</ArticleId></ArticleIdList></Reference><Reference><Citation>Souii A, Gharbi J, Ben M&#x2019;hadheb-Gharbi M. Molecular Analysis of RNA-RNA Interactions between 5&#x2032; and 3&#x2032; Untranslated Regions during the Initiation of Translation of a Cardiovirulent and a Live-Attenuated Coxsackievirus B3 Strains. Int. J. Mol. Sci. 2013;14, 4525&#x2013;4544. doi: 10.3390/ijms14034525</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14034525</ArticleId><ArticleId IdType="pmc">PMC3634434</ArticleId><ArticleId IdType="pubmed">23439556</ArticleId></ArticleIdList></Reference><Reference><Citation>Agol VI. Picornavirus genome: an overview. In Molecular Biology of Picornaviruses; Semler B.L.&amp; Wimmer E, Eds.; ASM Press, Washington DC, 2002; pp. 127&#x2013;148.</Citation></Reference><Reference><Citation>Gromeier M, Nomoto A. Determinants of poliovirus pathogenesis, in Molecular biology of picornavirus(Semler B. L. and Wimmer E., ed.), ASM Press, Washington DC, 2002;367&#x2013;379.</Citation></Reference><Reference><Citation>Bejan M, Christopher MH, William ET. Structure of the 5&#x2019; untranslated region of enteroviral genomic RNA. J. Virol. 2019;93:e01288&#x2013;19. doi: 10.1128/JVI.01288-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01288-19</ArticleId><ArticleId IdType="pmc">PMC6854513</ArticleId><ArticleId IdType="pubmed">31534036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Yousef G, Cunningham L. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5&#x2019;-nontranslated region does not contain major attenuation determinants. J. Med. Virol.1993;41, 129&#x2013;137. doi: 10.1002/jmv.1890410208</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890410208</ArticleId><ArticleId IdType="pubmed">8283174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Tu Z, Tracy S, Gauntt CJ.An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol.1994;135, 115&#x2013;130. doi: 10.1007/BF01309769</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01309769</ArticleId><ArticleId IdType="pubmed">8198437</ArticleId></ArticleIdList></Reference><Reference><Citation>Macadam AJ, Ferguson G, Burlison J, Stone D, Skuce R, Almond JW, et al.. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 1992;189, 415&#x2013;422. doi: 10.1016/0042-6822(92)90565-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(92)90565-7</ArticleId><ArticleId IdType="pubmed">1641974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya S, Das S. Mapping of secondary structure of the spacer region within the 5&#x2019;-untranslated region of the coxsackievirus B3 RNA: possible role of an apical GAGA loop in binding La protein and influencing internal initiation of translation. Virus Res.2003;108, 89&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">15681059</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn JJ, Chapman NM, Tracy S, Romero J. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5&#x2019; nontranslated region. J. Virol.2000;74, 4787&#x2013;4794. doi: 10.1128/jvi.74.10.4787-4794.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.10.4787-4794.2000</ArticleId><ArticleId IdType="pmc">PMC112001</ArticleId><ArticleId IdType="pubmed">10775617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>